ArticleHeliyon2023

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis.

Hafiza Arooba Riaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.